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ABSTRACT  
Background: In Parkinson’s disease (PD), impulsive-compulsive behaviors (ICBs) may develop as 
side-effect of dopaminergic medications. Abnormal incentive-driven decision-making, which is 
supported by the cognitive control and motivation interaction, may represent an ICBs signature. 
This systematic review explored whether structural and/or functional brain differences between PD 
patients with vs without ICBs encompass incentive-driven decision-making networks. 
Methods: Structural and functional neuroimaging studies comparing PD patients with and without 
ICBs, either de novo or medicated, were included. 
Results: Thirty articles were identified. No consistent evidence of structural alteration both in de 
novo and medicated PD patients were found. Differences in connectivity within the default mode, 
the salience and the central executive networks predate ICBs development and remain stable once 
ICBs are fully developed. Medicated PD patients with ICBs show increased metabolism and 
cerebral blood flow in orbitofrontal and cingulate cortices, ventral striatum, amygdala, insula, 
temporal and supramarginal gyri. Abnormal ventral striatum connectivity with anterior cingulate 
cortex and limbic structures was reported in PD patients with ICBs. 
Discussion: Functional brain signatures of ICBs in PD encompass areas involved in cognitive 
control and motivational encoding networks of the incentive-driven decision-making. Functional 



































































   
 




In Parkinson’s disease (PD), treatment of motor symptoms is provided by dopamine replacement 
therapies (DRT). However, in an estimated 30% of cases, DRT trigger impulsive-compulsive 
behaviors (ICBs) [1]. Individuals with ICBs are unable to resist or have diminished control over an 
appetitive urge, such as craving, to engage in behaviors that include gambling, sexual activity, 
eating, shopping. Engaging in such behaviors gives rise to feelings of pleasure or hedonia, but, left 
uncontrolled, can lead to relationship breakdown, financial difficulties, and health problems [2]. 
Despite the pervasive nature of ICBs in PD and their negative impact, much remains to be 
elucidated about their neural correlates. 
Each decision made to engage in a hedonic activity is a result of weighing up the predicted benefits 
of following that particular goal, traded-off against the mental effort involved in achieving the goal 
(or in resisting the urge to engage in that behavior) versus the alternative option(s) that are not 
pursued [3]. There is a consensus of opinion that cognitive control and motivation are both intrinsic 
and closely interrelated aspects of ‘incentive-driven decision-making’ and will therefore impact on 
the extent to which the goal directed behavior is regulated, or not as in the case of ICB. 
Cognitive control reflects the ability to flexibly organize and control the selection and deployment 
of on-going cognitive processes that include attention, memory, action-planning, and co-ordinate 
their activity to ensure successful delivery of goals in multitask environments [4]. 
Motivation can be defined as follows ‘when an external or internal incentive alters the biological 
system (i.e., generates a ‘motivated state’) to stimulate an observable change in behavior’ [3]. In 
other words, motivational states can be induced by offering rewards or negative incentives that lead 
to changes in cognitive control and influence behavior [5]. This highly dynamic and (two-way) 
interactive relationship is further influenced by individual differences in sensitivity to reward and 
punishment [5,6] and by modulation of the dopaminergic system, e.g. by DRT [7]. 
Cognitive neuroscience research suggests that incentive-driven decision-making reflects 
interactions between at least two brain networks on which cognitive control and motivational 
signals separately rely [3]. Cognitive control relies on frontal regions that interact via a local and 
global hierarchical structure. The motor and premotor cortices and the frontal eye fields, which 
together support sensory-motor control, are at the lowest level of the hierarchy. Rostrolateral 
prefrontal cortex occupies the intermediate level and has responsibility for domain-specific control 
of behavior, forming ‘schema’ from specific episodic information. At the apex of the hierarchy, and 
residing between caudal and rostral lateral prefrontal cortex, lies the mid-dorsolateral prefrontal 


































































   
 
   
 
4 
A parallel and synergistic network is suggested to govern the intensity of cognitive control amongst 
the networks conveying motivational signals [8]. This network is modulated by dopamine, and 
comprises the ventral striatum, the anterior cingulate cortex and, minimally, the dorsomedial frontal 
cortex. The latter interacts with rostrolateral and dorsolateral prefrontal cortex during performance 
monitoring and prediction error detection, implying that the two systems work together in 
‘deciding’ whether the salience or value of the incentives are worth increasing the strength of 
control and accepting the greater subjective cost that control involves [9–11]. 
This systematic review is aimed to explore whether ICBs are associated to abnormal structural 
and/or functional activation of the brain areas part of the cognitive control and motivational 
networks supporting incentive-driven decision-making. Brain signatures of de novo PD patients 
were also explored as putative markers of ICB vulnerability. 
Our systematic review included magnetic resonance imaging (MRI) and perfusion brain positron 
emission tomography (PET) or single-photon emission computed tomography (SPECT) imaging 
studies. Neuropharmacological PET or SPECT studies were not included as a recently published 
systematic review and meta-analysis explored this topic [12]. 
 
METHODS 
A systematic review was conducted to verify whether ICBs in PD are associated with changes in 
the brain structures supporting cognitive control and the network conveying motivational signals. 
Studies were selected if they compared PD patients with one or more ICB (ICB+) to those without 
any ICB (ICB-). Findings are presented separately for de novo PD patients and those treated with 
DRT. 
Inclusion and exclusion criteria 
We applied the following inclusion criteria: 1) between-group comparison between ICB+ and ICB- 
PD patients; 2) ICB status determined using standardized interviews with published criteria and/or 
rating scales with evidenced construct validity, and defined rates of sensitivity and specificity; 3) 
neuroimaging studies reporting grey matter structure using voxel-based morphometry (VBM) 
performed on structural MRI (sMRI), white matter connectivity using diffusion tensor imaging/ 
diffusion weighted imaging analysis (DTI)/(DWI) performed on sMRI, functional activation and 


































































   
 
   
 
5 
(fMRI), or brain perfusion using PET or SPECT at rest to investigate changes in regional cerebral 
blood flow. 
We excluded studies including PD patients with dementia, other neurological conditions other than 
PD, or with alcohol or any substance use disorder either at the moment when they were tested or in 
the past, because these conditions might be independently associated with structural and functional 
brain changes. Studies not screening for the absence of all ICB types in the ICB- groups were not 
included. 
Literature search strategy 
On the 10
th
 of August 2018, PubMed, Cochrane, EBSCO, and ISI Web of Science databases were 
searched for peer-reviewed papers in English, Spanish or Italian published since database inception. 
The search was further updated on the 30
th
 of March 2020. The protocol of the systematic review 
was pre-registered in PROSPERO (ID: CRD42018106365).   
RESULTS 
Search results 
Overall, 30 papers were included in the systematic review. Description of the systematic review’s 
phases is provided as Supplementary Material. 
Of the included 30 papers, 12 evaluated structural alterations [13–24], 12 evaluated functional 
alterations [25–36], and 6 included both structural and functional measures [37–42]. The study of 
Hammes et al. [18] was included in the structural section only, as no between groups analysis was 
done in functional alteration analysis. The study of Tessitore [33] was included in the functional 
section only as the sample and the structural alteration analysis were the same as Tessitore et al. 
[14]. The PRISMA diagram is shown in Figure 1. 
--insert Figure 1 around here please -- 
Data extraction 
The main outcomes for the structural imaging studies were the differences between ICB+ and ICB- 
groups in cortical and subcortical grey matter density measured with VBM, cortical thickness (Cth), 


































































   
 
   
 
6 
The main outcomes for the functional studies were the differences between ICB+ and ICB- groups 
in connectivity during resting state fMRI (rs-fMRI), brain perfusion during resting state, using PET 
or SPECT and brain activation during task performance using fMRI. 
 
STRUCTURAL STUDIES 
De novo PD patients 
Three studies examined ICBs in de novo PD patients (Table 1). Two were longitudinal [22,42], and 
the other one was cross-sectional in design [21]. 
Both longitudinal studies examined differences in local grey matter density using VBM [22,42], 
although Ricciardi et al. [17] also measured Cth. Zadeh et al. [16] examined subcortical white 
matter tracts using DTI. 
Demographic and clinical characteristics of the three studies are listed in Supplementary Table 1 
and described in Supplementary Material. 
Cortical and subcortical volume. Baseline and follow-up VBM measures did not dissociate 
between groups of de novo patients who went on to develop ICBs from those who did not [22,42].  
Cortical thickness. There was no difference in Cth at either baseline or follow-up between groups 
of de novo patients who went on to develop ICBs from those who did not [22]. 
Subcortical diffusion tensor imaging study. The single cross-sectional study evidenced decreased 
bilateral white matter connectivity in the cortico-thalamic tract, the cortico-pontine tract, the 
corticospinal tract, the superior cerebellar peduncle, and the middle cerebellar peduncle in de novo 
ICB+ compared to ICB- patients [21]. 
--insert Table 1 around here please-- 
Dopaminergic replacement therapy-medicated PD patients 
A total of 15 cross-sectional studies reported sMRI findings associated to ICBs in medicated PD 
patients (Table 2).  
Three studies reported grey matter cortical volume using VBM [13,19,40]. Seven reports explored 


































































   
 
   
 
7 
was reported in 9 studies [14,15,18,19,23,24,37–39], and subcortical white matter changes using 
DTI/DWI were described in further four studies [16,17,20,38]. 
Demographic and clinical characteristics of the 15 studies are listed in Supplementary Table 2 and 
described in Supplementary Material. 
Cortical and subcortical volume studies. One study reported evidence of increased cortical volume 
in the inferior frontal gyrus bilaterally, and the right-side caudal anterior cingulate between the 
ICB+ vs ICB- groups [15]. No other differences were detected at cortical level. 
Two studies reported volume reduction in the left [24] and right [14] nucleus accumbens, whereas 
two other studies found no volumetric differences [18,41] between groups. Borderline reduction of 
right external globus pallidus volume was reported in one study [40]. On the other hand, no 
between-groups volumetric differences were found in either the caudate nucleus, the globus 
pallidus, the putamen, [18,24,38,41], the thalamus [24,38,41], the habenula [39], the hippocampus 
[18,24,38,41] or the amygdala [18,24,38,39,41], although one study reported increase left amygdala 
volume in ICB+ [14]. Finally, one study reported volume reduction in the central and middle 
anterior (genu) corpus callosum of ICB+ vs ICB- [14]. 
Cortical thickness studies. Five of the nine studies examining Cth found abnormalities in ICB+ vs 
ICB-, although the direction of thickness varied, while four studies reported no differences 
[15,23,37,41]. 
Structures with cortical thinning included the left superior frontal and precentral gyri [14,38], right 
postcentral gyrus [19], pars orbitalis [14,39], pars opercularis, left postcentral area, rostral middle 
frontal area, superior and inferior parietal areas, lingual and parahippocampal gyri, bilateral caudal 
middle frontal and supramarginal areas [14], middle temporal gyrus and temporal pole [24].  
On the other hand, increased Cth was observed in the rostral anterior cingulate cortex and frontal 
pole [18], the left anterior cingulate cortex, left medial and lateral orbitofrontal cortex, left 
parahippocampal cortex, and left isthmus of the cingulate cortex [19].  
Subcortical diffusion tensor imaging studies. Three studies examined white matter integrity using 
fractional anisotrophy (FA), mean diffusivity (MD) [17,20,38], axial and radial diffusivity (RadD) 


































































   
 
   
 
8 
Structural degeneration (i.e., decreased FA and increased MD and RadD) was reported in the left 
uncinate fasciculus and parahippocampal tract (i.e, both decreased FA and increased MD/RadD) 
[38], and in pedunculopontine tract on the left [17] and right sides (i.e., increased RadD and MD) 
[38]. However, preserved white matter integrity (i.e., increased FA) was also reported in the 
anterior corpus callosum, partial left thalamic radiations, right dorsal and posterior cingula, right 
internal capsule (genu and posterior limbs), right superior temporo-occipital lobes, and right 
thalamic radiations [20]. The fibers of the corpus callosum were reported to be both more robust 
(i.e., increased FA) [20] and disrupted (i.e., increased RadD and MD) compared to ICB- [17,38]. 
A gambling task revealed that greater impulsivity was associated with lower structural connectivity 
between the left/right ventral striatum and the ventromedial prefrontal cortex in ICB+, with the 
opposite effect in ICB- [16]. 
--insert Table 2 around here please-- 
FUNCTIONAL STUDIES 
 
De novo PD patients 
Functional imaging correlates of ICBs in de novo PD patients have been investigated in one 
longitudinal study only using rs-fMRI (Table 3).  
Demographic and clinical characteristics of the study are reported in Supplementary Table 3 and 
described in Supplementary Material. 
Resting-state fMRI. At baseline, patients who went on to develop ICBs showed increased 
connectivity in the left orbitofrontal cortex, decreased connectivity in the left supramarginal gyrus, 
left precuneus and right middle temporal gyrus compared to patients without ICBs at follow-up. 
--insert Table 3 around here please-- 
Dopaminergic replacement therapy-medicated PD patients 
Seventeen cross-sectional functional imaging studies investigated ICBs in medicated PD (Table 4).  
Two studies reported measures of brain metabolism using resting state PET [33,41]. Three reports 
explored cerebral blood flow measures, two of them using resting state SPECT ON-medication 
[25,26], and one using arterial-spin-labelling ON- and OFF-medication [34]. Five studies reported 


































































   
 
   
 
9 
discounting task ON- and OFF-medication [35], reward-related visual cues OFF- [29] and ON-
medication [30,32] and the Iowa Gambling task ON-medication only [27]. Further six studies 
investigated spontaneous low frequency BOLD fluctuations using rs-fMRI [28,31,37–40]. Only a 
single study to date has examined changes in dynamic functional connectivity over time and this 
was conducted in ON-medicated patients [36]. 
Demographic and clinical characteristics of the 17 studies are listed in Supplementary Table 4 and 
described in Supplementary Material. 
Resting-state fMRI studies 
ICB+ vs ICB- comparison showed reduced connectivity between the basal ganglia nuclei and 
frontal cortical areas [40], between the habenula and left frontal and precentral cortices, and 
between right amygdala and hippocampus [39] and in the dorsolateral prefrontal cortex and inferior 
parietal cortex [28], and between the left anterior putamen and the left inferior temporal and 
anterior cingulate gyrus, but no difference in connectivity in the ventral striatum [37]. 
On the other hand, ICB+ compared to ICB- showed increased connectivity between the ventral 
striatum and limbic structures [31], between the striatum and the habenula, the amygdala, the 
thalamus and bilaterally [39], in the right ventral striatum and bilateral insula, and in the left middle 
temporal gyrus [28]. 
In the single study that examined dynamic functional connectivity over time, ICB+ vs ICB- were 
found to be engaged for longer in a brain configuration pattern characterized by strong ‘within’ 
network connections between superior temporal lobe, fronto-insular and cingulate cortices, at the 
expense of connectivity with other networks. The same study also reported increased local 
efficiency within the superior temporal lobe, fronto-insular and cingulate cortices [36]. 
Resting-state brain perfusion and brain metabolism 
Two studies found increased metabolism in the right middle and inferior temporal gyri [33], and in 
the orbitofrontal cortex, amygdala, insula, posterior cingulate cortex, parahippocampus and 
supramarginal gyri [41] when comparing ICB+ to ICB- patients. Increased regional cerebral blood 
flow was also evident in the orbitofrontal cortex, hippocampus, amygdala, insula, and the ventral 
pallidum in ICB+ patients vs ICB- ones [25]. However, OFF-medication, there was no difference in 
regional cerebral blood flow in the striatum and frontal cortex, whilst ON-medication increased 
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Connectivity was decreased between anterior cingulate cortex and the striatum [26] and the left 
caudate and the right parahippocampus [33], but increased between the right middle, the inferior 
temporal gyri, the mesocorticolimbic system, and orbitofrontal regions [33]. 
Task-based fMRI studies 
Task-based fMRI studies consistently showed increased activation of reward-related areas; ICB+ 
patients with gambling disorder showed increased BOLD signal in the anterior cingulate cortex, 
medial and superior frontal gyri, the precuneus, inferior parietal lobule, and ventral striatum after 
gambling-related visual cue exposure in comparison to ICB- ones [29]. A similar functional brain 
activation profile has been reported in PD patients with hypersexuality after exposure to visual 
sexual cues [32,35]. The BOLD signal was also reported to be increased in the ventral striatum of 
ICB+ patients with dopamine dysregulation syndrome (compulsive craving of dopaminergic 
medication) after exposure to drug-related cues as compared to ICB- ones [30]. 
On a temporal discounting task, subjective value of the delayed reward was negatively correlated 
with activity in the ventromedial prefrontal cortex and ventral striatum in ICB+, with the opposite 
pattern in ICB- patients [35]. ICB+ vs ICB- showed increased BOLD signal in the right subthalamic 
nucleus, right inferior frontal gyrus, and right ventral striatum while performing the Iowa Gambling 
Task [27].  
--insert Table 4 around here please-- 
 
DISCUSSION 
The main objective for this systematic review was to report whether ICBs in PD are marked by 
abnormal brain structures and functional networks in areas related to incentive-driven decision-
making, and whether brain changes predate ICB onset. 
The main findings from structural imaging studies were inconclusive. There was no consistent 
association between ICB, both in medicated and de novo PD patients, and changes in VBM, Cth, or 
white matter tracts in lateral prefrontal areas related to domain-specific and domain-general 
cognitive control [4], or in medial prefrontal cortex and subcortical structures implicated in 
motivation and salience response. 
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The first key finding is that changes in resting-state networks activation were most consistently 
reported in the salience network, the central executive network (CEN) and the default mode 
network (DMN), both in medicated and de novo patients. Medicated ICB+ showed reduced 
functional connectivity within the CEN and increased connectivity in the DMN and salience 
network [28]. The same results were reported in de novo PD patients who later developed ICBs, 
except for the DMN that showed decreased connectivity compared to ICB- patients [42]. The DMN 
is active during internally-directed thoughts such as mind wondering, and it is suspended during 
cognitively-demanding tasks and goal-directed behaviors. It includes the ventromedial prefrontal 
cortex, posterior cingulate cortex, inferior parietal cortex and medial temporal lobe. The CEN is 
engaged when a cognitively demanding task or a goal-directed behavior requiring attention is being 
performed, and is composed by the dorsolateral prefrontal cortex and inferior parietal cortices 
[28,43]. The salience network is activated by salient or rewarding stimuli (cognitive, emotional or 
homeostatic) therefore facilitating the DNM/CEN switching. It includes limbic-paralimbic 
structures, such as anterior insula, the anterior cingulate cortex, and the ventral striatum. In 
summary, resting-state networks findings highlight abnormal functional connectivity within regions 
involved in cognitive control (i.e., CEN) and in motivational processing (i.e., salience network) 
[4,8] which predate ICBs and remain stable once are fully developed. A limitation of the static 
functional connectivity studies is that connectivity is time-invariant. Dynamic functional 
connectivity takes into account the time-variant dynamic coupling that exists between nodes in a 
network [44,45]. The study by Navalpotro-Gomez et al. (2020) is the only one to date to examine 
time-variant functional connectivity of ICB in PD, and found that ICB+ were engaged across time 
in a brain configuration pattern characterized by lack of between-network connections at the 
expense of strong within-network connections in temporal, frontoinsular and cingulate cortices, all 
key nodes of the salience network. The increased temporal predominance of this state may be a 
consequence of, or lead to a reduction in the frequency of transitions between brain states, which is 
important for neural flexibility mediated through reconfiguration of general brain state organization 
[44]. The abnormally high connectivity within the salience network may lead ICB+ patients to long 
and unregulated motivational states focused on or abnormally weighted towards reward-seeking 
behaviors. We may speculate that, along time, synaptic plasticity related to craving causes long-
term potentiation in incentive-driven decision-making networks, as supported by evidence of ICB 
development years after DRT initiation [46]. Once DRT doses is decreased, ICB may remit 


































































   
 
   
 
12 
The second key finding is that resting-state studies showed changes that mainly reflect an increase 
in brain metabolism [33,41] and cerebral blood flow [25,34] in brain areas belonging to the 
incentive-driven decision-making networks, such as the orbitofrontal cortex, amygdala, insula, 
ventral striatum, posterior cingulate cortex, parahippocampus and hippocampus, middle and inferior 
temporal, and supramarginal gyri. It has been suggested that the enhanced overdrive of the 
mesocorticolimbic system in response to DRT requires preserved metabolism to take action, and 
this may explain why ICB- patients, who show lower metabolic preservation are less keen to 
develop ICB under DRT [41]. 
The third key finding is that resting-state studies showed abnormal ventral striatal connectivity in 
ICB+. Ventral striatum show increased connectivity with limbic structures (e.g., habenula, 
amygdala, thalamus, insula) [28,31,39], and decreased connectivity with the anterior cingulate 
cortex [26]. Furthermore, increased cerebral blood flow in the ventral striatum and frontal cortex is 
evident when ON- but not OFF-medication [34]. Taken together these results not only evidence that 
ventral striatum is a brain area consistently associated with ICBs in PD but also that it is sensitive to 
the effect of DRT in ICB+ group only. Abnormal frontostriatal connectivity may disrupt integration 
of cognitive control and motivational inputs during incentive-driven decision-making. 
The fourth key finding is that task-based fMRI studies showed increased rather than decreased 
BOLD signal during exposition to reward-related cues, and during tasks measuring risk-taking and 
temporal discouting in the subthalamic nucleus, inferior frontal gyrus and ventral striatum, anterior 
and posterior cingulate cortex, ventromedial prefrontal cortex, and orbitofrontal cortex 
[27,29,30,35]. The pattern of activation is generalized across ICBs type albeit each study focused 
on a specific and different ICB. 
METHODOLOGICAL CONSIDERATIONS 
Some limitations should be acknowledged (Supplementary Table 5). 
First, in some studies ICBs were diagnosed using the Questionnaire for Impulsive-Compulsive 
Disorders in Parkinson’s disease [21,22,40], which is a validated screening tool with high 
sensitivity (94%) but low specificity (72%) to ICBs in PD, thereby possibly inflating the number of 
false positive subjects. Other studies used the Minnesota Impulsive Disorders Interview only 
[19,28], without specifying how the ICBs not included in the interview (i.e. binge-eating, 
punding/hobbyism, and dopamine dysregulation syndrome) were investigated. Although screening 


































































   
 
   
 
13 
a clinical interview based on diagnostic criteria. Caregiver should also be interviewed separately to 
confirm the diagnosis. Between-studies heterogeneity in procedures to ascertain ICB may account 
for the discrepancy in their findings. 
Second, most of the studies were constrained by small sample size, with the smallest including 7 
ICB+ and 7 ICB- [29], the largest including 58 ICB+ and 52 ICB- [14], and none of them reporting 
power analysis calculation. Underpowered studies may not detect a true effect and may reduce the 
likelihood for a significant result to reflect a true effect [47]. When economic resources are limited, 
larger samples can be obtained through collaborative research or using available shared databases 
[48]. 
Third, protocols of acquisitions and data analysis were not uniform across studies thereby limiting 
comparison. There is variability in scan duration, pre-processing and analysis, statistical threshold 
and methods to correct for multiple comparisons, with more liberal statistical thresholding 
procedure such as the false discovery rate, which in some cases may have inflated the false positive 
rate [14,17,19,21,25,29,30,32,39]. Methodological differences can explain the lack of consistency 
in the results reported in this systematic review. For example, the inclusion of the ventral caudate 
and putamen in the ventral striatum seed region, rather than the nucleus accumbens alone [31,37]. 
Replication studies using the same acquisition and analysis protocol are needed. 
Fourth, a potential bias factor in resting-state studies is whether patients are in ON or OFF state. 
Most of the studies did not provide information to ensure that patients were in a stable ON state 
during MRI scan that may be long-lasting. Strategies that could be adopted include two resting-state 
sessions to increase reliability, exclude patients with unpredictable ON-OFF changes, or measure 
delta changes between motor symptoms score ON vs OFF-medication.  
Fifth, ICB+ and ICB- were not always fully matched for clinical variables that may predict or be 
associated with ICBs, thus these covariates might have contributed to neuroimaging findings. For 
example, in some studies ICB+ patients had higher levels of apathy and depression compared to 
ICB- ones [17,36,38,39]. The lack of consistency in the results may be due to between-studies 
differences in PD duration (>10 years), co-presence of non-motor symptoms other than ICBs, or 
gender imbalance, since gender has been differently associated with specific ICB types [49]. 
Disease-related gender-specific patterns of intrinsic brain connectivity, which may be differently 
affected by DRT, have been reported [50]. 
Finally, multiple vs. single ICBs showed higher right temporal metabolism [33], although no 
structural differences [18], suggesting neurobiological differences across ICB subtypes. However, 


































































   
 
   
 
14 
patients, including those focusing on a single ICB [25,26,29,30,32,35,39], did not allow separate 
ICB subtype analyses. 
 
CONCLUSIONS 
Imaging studies have provided evidence of functional differences between ICB+ and ICB- in brain 
regions encompassing cognitive control and motivational processing networks, whose interactions 
support incentive driven decision-making. 
In the last decade over 500 studies on ICBs in PD ranging from clinical to neuroimaging and 
genetic risk factors have been published [51], however we still miss a firm understanding of ICBs 
neural signature. With a better understanding of ICBs underpinnings, pharmacological and/or non-
pharmacological interventions targeting specific brain areas may be developed. 
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FIGURE LEGENDS 
Figure 1. PRISMA diagram of the study (www.prisma-statement.org). Legend. ICBs, impulsive-
compulsive behaviors; MRI, magnetic resonance imaging.  
Table 1. Key details of the three structural studies on de novo patients including imaging technique, patient numbers, matching/unmatching variables, and outcome. 
Ref. Imaging 
technique 
Subjects  ICB 
diagnosis 
ICB type: N Matched variables Unmatched variables Differences in brain regions Findings:  
ICB+ vs ICB- 
Longitudinal 
Ricciardi et 
al. 2017  
 
VBM, Cth  
 
ICB+: 42  
ICB-: 42  
QUIP NR Sex, age, education, PD 
duration, H&Y, UPDRS-









ICB+ = ICB- 
Tessitore, De 
Micco et al. 
2017 
 
VBM ICB+: 15  




HS:6; BE:5; GD:2; CS:2  
 
Sex, age, education, PD 
duration, H&Y, UPDRS-
III, total LEDD; DA-
LEDD, BDI-II, MMSE 
NR No differences ICB+ = ICB- 
Cross-sectional  







ICB–: 68  
QUIP HS: 1; CS: 1; BE: 8; 
Hobbyism: 2; Punding: 5; 
walking/driving+HS: 2; 
BE+ punding: 1; CS+HS: 1; 
CS+BE+punding: 1 
Sex, age, education, PD 
duration, H&Y, UPDRS-
III, MoCA score 
GDS: ICB+<ICB- Decreased bilateral white matter connectivity in the 
cortico-thalamic tract, the cortico-pontine tract, the 
corticospinal tract, the superior and middle 
cerebellar peduncles 
ICB+ ↓ 
Legend. BDI-II: Beck depression inventory II; BE: binge-eating; CS: compulsive shopping; CTh: cortical thickness; DA-LEDD: dopamine agonists equivalent daily dose; GD: gambling disorder; GDS: geriatric depression scale; H&Y: 
Hoehn & Yahr score; HS: hypersexuality; ICB: impulsive compulsive behaviour; ICB+: PD patients with ICB; ICB-: PD patients without ICB; MMSE: Mini-mental state examination; MoCA: Montreal cognitive assessment; MRI: 
magnetic resonance imaging; NR: not reported; PD: Parkinson’s disease; ref.: reference; QUIP: Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s disease; QUIP-rs: Questionnaire for Impulsive-Compulsive Disorders in 




Table 2. Key details of the ten structural studies on DRT patients including imaging technique, patient numbers, matching/unmatching variables, and outcome.  
Ref. Imaging 
technique 
Subjects  ICB diagnosis ICB type: N Matched variables Unmatched variables Differences in brain region* Findings: 
ICB+ vs ICB- 
Cross-sectional 
Biundo et al. 
2011 
 
VBM ICB+: 33  
ICB-: 24  
MIDI; DSM-IV-
TR criteria; clinical 
interview (patient 
and carergiver) 
HS: 11; CS: 9; GD: 1; 
punding: 2; ICB-M: 12 
Sex, PD duration, 
UPDRS-III, total LEDD, 
DA LEDD, BDI, MMSE 
 
Age: ICB+<ICB-** No differences ICB+ = ICB- 





ICB+: 58  





HS: 6; CS: 7; GD: 2; 
hoarding: 2; impulsive 
aggression: 1; M-ICB: 40 
Sex, education, H&Y, 
UPDRS-III, DA-LEDD, 
MMSE, BDI-II 
age**; age at PD onset: 
ICB+<ICB-; PD 
duration: ICB+>ICB-
**; total LEDD: 
ICB+>ICB-** 
CTh: left precentral and postcentral area, 
superior frontal and rostral middle frontal 
area, pars orbitalis, pars opercularis, superior 
and inferior parietal areas, lingual and 
parahippocampal gyrus, and bilaterally in the 
caudal middle frontal and supramarginal 
areas. 
Subcortical volumes: right NAc, and in the 













Canu et al. 
2017 
DTI ICB+: 21  







Sex, age, education, age 
at PD onset, PD duration, 
H&Y, UPDRS-III, 





Genu of corpus callosum adjusting for 
depression and apathy scores; left PPT 





CTh ICB+: 19  





HS: 14; GD: 7; BE: 7; CS: 5 
 
Sex, age, PD duration, 




NR No differences ICB+ = ICB- 
Hammes et 
al. 2020 
CTh ICB+: 18 
ICB-: 44 
QUIP-rs GD: 3; HS: 11; CS:5; BE: 
10; M-ICB: 7 
 
 
NR NR CTh: no differences ICB+ = ICB- 
 
Hlavata et al. 
2020 
CTh ICB+: 8 
ICB-: 16 
Clinical interview GD: 5; HS: 2; CS: 1; BE: 3; 
hobbyism: 1; punding: 1; 
hoarding: 1; pedantry: 1; 
excessive cleaning: 1 
 
NR NR CTh: no differences  
Subcortical volumes: bilateral pars orbitalis, 
right caudal anterior cingulate 













GD: 4; HS: 4; CS: 1; BE: 3; 
punding: 15; DDS: 5; BE+ 
punding: 1; GD + punding: 
1; DDS + punding: 1 
Sex, age, education, age 
at PD onset, PD duration, 






CTh: left superior frontal and precentral gyri.  
 
DTI: GM: no differences 
WM: left parahippocampal tract and right 




















HS: 2; BE: 3; hobbyism: 3; 
BE + hobbyism: 1 
Sex, age, education, age 
at PD onset, PD duration, 
UPDRS-III, total LEDD, 
DA-LEDD 
 
NR CTh: no differences 
Subcortical volumes: no differences. 
ICB+ = ICB- 






ICB+: 22  
ICB-: 30  
Interview including 
a semi-structured 
part (patients and 
caregivers) 
Punding: 17; Punding + BE: 
2; Punding + GD: 1; 
Punding + DDS: 1; Punding 
+ HS: 1 
Sex, age, education, age 
at PD onset, PD duration, 
H&Y, UPDRS-III, total 
LEDD, DA-LEDD 
NR CTh: right pars orbitalis of the inferior frontal 
gyrus 
Subcortical volumes investigated (habenula 
and amygdala): no differences 
ICB+  
 
ICB+ = ICB- 
Table 2
  
Mosley et al. 
2019 




GD: 10; HS: 9; BE: 1; CS: 
3; DDS: 2; hobbyism: 1 
 
Age, PD duration, H&Y, 
total LEDD 
NR In a gambling task, increased structural 








ICB+: 18  





GD: 4; HS: 3; BE: 1; CS: 1; 
HS+CS: 2; GD+CS: 1; 






Sex, age, age at PD onset, 




III (OFF medication): 
ICB+>ICB-**; H&Y: 
ICB+>ICB- 
CTh: rostral ACC and frontal pole 
Subcortical volumes: no differences 
ICB+ 
ICB+ = ICB- 





ICB+: 11  
ICB-: 15 
QUIP-rs HS: 1; punding: 3; 
hobbyism: 1; DDS: 2; 
HS+CS: 1; BE+hobbyism: 
1; GD+hobbyism: 1; 
HS+BE+CS+DDS+punding: 
1 
Age, age at PD onset, 
disease duration, 
UPDRS-III (OFF), H&Y, 
total LEDD, LD-LEDD 
DA-LEDD: ICB+>ICB- Cth: right middle temporal gyrus and bilateral 
temporal pole 





et al. 2018 




GD: 1; HS: 9; CS: 7; BE: 
11; others: 6; (9 were in 
combination) 
Sex, age, age at PD onset, 
PD duration, UPDRS-III, 
total LEDD, MoCA, 
NART-R 
 
NR Right GPe (uncorrected threshold only)  ICB+  
Tessitore et 





ICB+: 15  
ICB-: 15  
MIDI HS: 13; BE: 8; GD: 1 
 
Sex, age, education, PD 
duration, H&Y, UPDRS-
III, total LEDD, DA-
LEDD, HAM-D, HADS, 
MMSE 
__ VBM: no differences 
 
CTh:  
Left ACC, left medial frontal cortex, left 
lateral OFC, left parahippocampal cortex, and 
left isthmus of cingulate cortex; 
Right postcentral gyrus 
 







Yoo et al. 
2015 
DTI ICB+: 10  
ICB-: 9 





Sex, age, PD duration, 
H&Y, UPDRS-III, total 
LEDD, DA-LEDD, GDS, 
MMSE 
NR Anterior corpus callosum, partial left thalamic 
radiations, right dorsal and posterior 
cingulum, right internal capsule (genu and 
posterior limbs), right superior temporo-
occipital lobes, and right thalamic radiations 
ICB+ 
Legend. ACC: anterior cingulate cortex; BDI: Beck depression inventory; BDI-II: Beck depression inventory II; BE: binge eating; CS: compulsive shopping; CTh: cortical thickness; DA-LEDD: dopamine agonists equivalent daily dose; 
DDS: dopamine dysregulation syndrome; DSM-IV-TR: Diagnostic and statistical manual of mental disorders – fourth edition text revision; DTI: diffusion tensor imaging; DWI: diffusion weighted imaging; GD: gambling disorder; GDS: 
geriatric depression scale; GM: grey matter; GPe: external portion of the globus pallidus; HADS: Hospital anxiety and depression scale; HAMA: Hamilton anxiety rating scale; HAM-D: Hamilton depression rating scale; HDRS: Hamilton 
depression rating scale; HS: hypersexuality; H&Y: Hoehn & Yahr score; ICB: impulsive compulsive behaviour; ICB+: PD patients with ICB; ICB-: PD patients without ICB; LD-LEDD: levodopa equivalent daily dosage levodopa only; 
M-ICB: multiple ICB; MIDI: Minnesota Impulsive Disorders Interview; MMSE: Mini-mental state examination; MoCA: Montreal cognitive assessment; MRI: magnetic resonance imaging; NAc: nucleus accumbens; NART-R: National 
adult reading test-revised; OFC: orbitofrontal cortex; PD: Parkinson’s disease; PPT: pedunculopontine tract; QUIP: Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s disease; QUIP-rs: Questionnaire for Impulsive-
Compulsive Disorders in Parkinson’s disease – rating scale; ref.: reference; Total LEDD: levodopa equivalent daily dose total; UPDRS-III: unified Parkinson’s disease rating scale part III (motor subscale) score; VBM: voxel-based 
morphometry; vmPFC: ventromedial prefrontal cortex; VS: ventral striatum; WM: white matter. *comparison between ICB+ vs ICB- ** variable differing between groups but included as covariate in the analyses.  
 
Table 3. Key details of the single functional study on de novo patients including imaging technique, patient numbers, matching/unmatching variables, and outcome.  
Ref. Imaging 
technique 
Subjects  ICB 
diagnosis 
ICB type: N Matched variables Unmatched 
variables 




et al. 2017  
rs-fMRI 
 
ICB+: 15  




HS: 6; BE: 5; 
GD:2; CS:2 
Sex, age, education, PD 
duration, H&Y, UPDRS-III, 
Total LEDD, DA-LEDD, BDI-
II, MMSE 
NR Increased connectivity in the left OFC within the SN; DMN 
coupling with the right CEN 
 
Decreased connectivity in the left supramarginal gyrus within 
the right CEN; the left precuneus and right middle temporal 





Legend. BDI-II: Beck depression inventory II; BE: binge eating; CEN: central executive network; CS: compulsive shopping; DA-LEDD: dopamine agonists equivalent daily dose; DMN: default-mode network; GD: gambling disorder; 
HS: hypersexuality; H&Y: Hoehn & Yahr score; ICB: impulsive compulsive behaviour; ICB+: PD patients with ICB; ICB-: PD patients without ICB; MMSE: Mini-mental state examination; NR: not reported; OFC: orbitofrontal cortex; 
PD: Parkinson’s disease; QUIP-rs: Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s disease – rating scale; Ref.: reference; rs-fMRI: resting state functional magnetic resonance imaging; SN: salience network; Total 
LEDD: levodopa equivalent daily dose total; UPDRS-III: unified Parkinson’s disease rating scale part III (motor subscale) score. *comparison between ICB+ vs ICB-. 
 
Table 3
Table 4. Key details of the thirteen functional studies on DRT patients including imaging technique, patient numbers, matching/unmatching variables, and outcome.  
Ref. Imaging 
technique 
Subjects  ICB 
diagnosis 
ICB type: N Matched variables Unmatched 
variables 
Criteria for defining 
medication state 







rs-fMRI  ICB+: 19  





BE: 7; CS: 5 
 






NR Patients assessed after 
having received their usual 
antiparkinsonian 
medication 
Decreased functional connectivity between left 
anterior putamen, left inferior temporal and anterior 
cingulate gyri 
ICB+  
Cilia et al. 
2008 
 
SPECT ICB+: 11  












Sex, age, age at PD 





NR Patients assessed in the 
morning during 
medication use 
Increased brain perfusion: right OFC to insula, right 
hippocampus to parahippocampal gyrus, right 
amygdala, right ventral pallidum to NAc, left insula, 
right precuneus to cuneus and PCC, left precuneus to 
cuneus and PCC. 
ICB+ 
Cilia et al. 
2011 
 
SPECT  ICB+: 15 











NR Patients assessed in the 
morning on-medication 
Connectivity analysis: lack of covariance between the 
VLPFC and ACC, PCC; between the ACC and VS 
 
Presence of covariance of ACC with insula, 
supplementary motor area, and cerebellum; VLPFC 
with ventral pallidum; medial prefrontal cortex with 















 (patient and 
spouse) 
Hobbyism:11; 
HS: 10; CS: 4; 
BE:12 











Before MRI scan, patients 
assessed by UPDRS III in 
the on-DA and off-
Dopamine (LD + DA) 
state. Off condition: 
withdrawal for at least 36 
hours for DA and 16 hours 
for LD. On condition: after 
taking prescribed DA 
medication, having 
withheld LD for at least 16 
hours 
 
OFF state: no differences 
 
ON state: CBF increase in VS and frontal cortex, 
























NR MRI scan performed after 
overnight drug washout (at 
least 12 hours) 
Increased cue-related BOLD response bilaterally in 
the ACC, medial and superior frontal gyri and 
precuneus with right prevalence, right inferior 
parietal lobule, and left VS 
ICB+ 












HS: 2; HS+CS: 




Age, PD duration, 
UPDRS-III (ON and 
OFF), total LEDD, 
LD-LEDD, DA-
LEDD 
NR MRI scan performed both 
ON and OFF in 
counterbalanced order, one 
day apart. ON: 1h after a 
levodopa challenge (single 
supraliminar levodopa 
ON medication, when exposed to erotic picture after 
waiting for longer periods: increase activity in the 
anterior medial prefrontal/rostral ACC. 
 
ICB+ negative correlation between subjective value 
of the delayed reward and activity in the medial 
ICB+ 
Table 4
dose intake corresponding 
to 150% of the usual 
morning dose). OFF: after 













GD: 4; HS: 4; 
CS: 1; BE: 3; 
punding: 15; 
DDS: 5; BE+ 
punding: 1; GD + 
punding: 1; 
DDS+ punding: 1 
Sex, age, education, 














NR Decreased functional connectivity of the right 
precentral gyrus, rolandic operculum and superior 
temporal gyrus within the sensorimotor network 
ICB+  
 















All DDS with at 
least another ICB 
(GD; BE; HS; 
BE+ GD; 
BE+HS) 









Participants scanned in 
OFF medication 
condition and in ON 
medication condition 
after receiving an oral 
dose of LD  
45 min prior to the scan 
starting. 
Motor performance was 
assessed with the 
UPDRS-III at 
baseline and immediately 
before scanning to ensure  
response to medication 
 
Both ON and OFF medication (neural-cues): 
increased BOLD activity in the VS, ACC, BA 6, IFG 
and midbrain  
post drug-cues vs. neutral-cues exposure: increased 




Lahoz et al. 
2020 





HS: 2; BE: 3; 
hobbyism: 3; 
BE+hobbysm: 1 
Sex, age, education, 
age at PD onset, PD 
duration, UPDRS-
III, total LEDD, 
DA-LEDD 
NR All the neuroimaging 
acquisitions were 
performed in ON state 
Glucose metabolism in PCC, bilateral supramarginal 
gyrus, right precuneus, bilateral fusiform gyrus, 
bilateral lingual, parahippocampal gyrus, left anterior 
insula, bilateral amygdala, bilateral uncus, bilateral 
















Punding + BE: 2; 
Punding + GD: 
1; Punding + 
DDS: 1; Punding 
+ HS:1 
Sex, age, education, 




NR NR Increased connectivity of the left habenula and the 
thalamus and striatum bilaterally and left posterior 
cingulum; between the right habenula and dorsal 
thalamus bilaterally; between the left amygdala and 
the thalamus bilaterally and left striatum; between the 
right amygdala and the left thalamus and caudate 
 
Decreased connectivity between the left habenula and 
the left frontal cortex; between the right habenula 
and the left posterior parietal regions; between the 


















HS: 3; BE: 2; 
CS: 1; HS+BE: 




Sex, age, education, 
premorbid IQ, PD 
duration, UPDRS-
III, H&Y, total 
LEDD, DA-LEDD 
NR PD patients were studied 
under the effect of their 
usual dopaminergic 
medication.  
Engaged for a longer time in a brain configuration 
patter characterized by enhanced within-network 
functional connectivity in temporal, frontoinsular, 































Sex, age, education, 
premorbid IQ, PD 
duration, UPDRS-
III, H&Y, total 
LEDD, DA-LEDD 
NR All assessments and MRI 
scanning of PD patients 
were done in the morning 
while they were still under 
the effect of their first 
regular dose of 
dopaminergic medication. 
During IGT performance, hyperactivation in right 





















Sex, age, PD 
duration, total 
LEDD, DA LEDD, 
CES-D 
NR Patients refrain from 
taking all dopaminergic 
medications prior to the 
off-dopamine therapy scan 
(16 h for LD, 36 h for DA) 
For the on-DA scan, 
patients took their 
prescribed DA dosage (but 
not LD) 
 
Increased connectivity between VS and the dorsal 
anterior cingulate gyrus, OFC, insula, putamen, 




























Sex, age, PD 
duration, UPDRS-III 








Patients scanned in OFF 
medication condition and 
in ON 
medication condition 
after receiving an oral 
dose of LD  
45 min prior to the scan 
starting. 
Motor performance was 
assessed with the 
UPDRS-III at 
baseline and immediately 
before scanning to ensure  
response to medication 




Sexual cues vs neutral stimuli: 
Increased BOLD activity in the OFC, ACC, PCC, left 
amygdala, VS, hypothalamus, anterior prefrontal 
cortex, superior parietal lobule, lateral right inferior 
parietal lobule (in ON and OFF) 
Decreased BOLD activity in the insula and right 













et al. 2018 








Sex, age, age at PD 




NR Patients were tested while 
their symptoms were being 
well controlled by DRT. 
UPDRS-III was used to 
assess motor symptoms 
 
Increased connectivity between the left subthalamic 





al. 2017  
rs-fMRI  ICB+: 15 
ICB-: 15  
MIDI HS:13; BE:8; 
GD:1 
Sex, age, education, 
PD duration, H&Y, 
UPDRS-III, total 
-- Patients were assessed in 
the morning during the ON 
medication state 
Increased activity in bilateral insula and right ventral 














Verger et al. 
2018 
 
PET ICB+: 18 





GD:4; HS: 2; 
CS:3 
GD+HS:4; CS+ 
GD:3; CS+ HS:3; 
ICB+DDS:3 
Sex, age, PD 
duration, H&Y 
(OFF medication), 
UPDRS-III (ON and 
OFF medication), 
total LEDD, DA-
LEDD, Mattis scale, 
BDI, LARS 
NR NR Increased metabolism in right middle and inferior 
temporal gyri 
 
Increased positive connectivity with right middle and 
inferior temporal gyri and right middle temporal 
gyrus, right middle and inferior frontal gyri, right 
middle and superior temporal gyri and parietal 
inferior lobule 
 
Increased negative connectivity with right middle and 















Legend. ACC: anterior cingulate cortex; AMNART: American version of the national adult reading test; ASL: arterial spin labeling; BA: Brodmann Area; BDI: Beck Depression Inventory; BE: binge eating; BOLD: blood oxygen level 
dependent signal; CBF: cerebral blood flow; CEN: central executive network; CESD-R: Center for Epidemiologic Studies Depression Scale Revised; CS: compulsive shopping; DA: dopamine agonists; DA-LEDD: dopamine agonists 
equivalent daily dose; DDS: dopamine dysregulation syndrome; DSM-IV-TR: Diagnostic and statistical manual of mental disorders – fourth edition text revision; DLPFC: dorsolateral prefrontal cortex; DMN: default mode network; 
DRT: drug replacement therapy; fMRI: functional magnetic resonance imaging; GD: gambling disorder; GDS: geriatric depression scale; HADS: Hospital anxiety and depression scale; HAM-D: Hamilton depression rating scale; H&Y: 
Hoehn & Yahr score; HS: hypersexuality; IA: internet addiction; ICB: impulsive compulsive behaviour; ICB+: PD patients with ICB; ICB-: PD patients without ICB; IFG: inferior frontal gyrus; LARS: Lille Apathy Rating Scale; LD-
LEDD: levodopa equivalent daily dosage levodopa only; LD: levodopa; MIDI: Minnesota Impulsive Disorders Interview; MMSE: Mini-mental state examination; MoCA: Montreal cognitive assessment; MRI: magnetic resonance 
imaging; NAc: nucleus accumbens; NART-R: National adult reading test-revised; OFC: orbitofrontal cortex; PET: positron emission tomography; PCC: posterior cingulate cortex; PD: Parkinson’s disease, ref.: reference; QUIP: 
Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s disease; QUIP-rs: Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s disease – rating scale; rs-fMRI: resting state functional magnetic resonance imaging; 
SOGS: South Oaks gambling screen test; SN: salience network; SPECT: single photon emission computed tomography; Total LEDD: levodopa equivalent daily dose total; UPDRS-III: Unified Parkinson’s disease rating scale part III 
(motor subscale) score; VLPFC: ventrolateral prefrontal cortex; vmPFC: ventromedial prefrontal cortex; VS: ventral striatum; *comparison between ICB+ vs ICB-. 
 
 
Records identified through database 
searching (n = 720) 
 
PubMed (n = 230) 
Cochrane (n = 32) 
EBSCO (n = 184) 
ISI Web of Science (n = 274) 
Additional records identified 
through other sources 
(n = 2) 
Records after duplicates removed 
(n = 297) 
Records screened 
(n = 299) 
Records excluded 
(n = 260) 
Full-text articles assessed 
for eligibility 
(n = 39) 
Full-text articles excluded, 
with reasons 
(n = 9) 
 
ICB diagnostic procedure not 
described = 1 
No ICB+ vs. ICB- MRI 
comparison = 1  
Not all ICB screened = 4 
Dementia not clearly excluded = 1 
Previous or current substance use 
disorder = 2 
Studies included in 
qualitative synthesis 
(n = 30) 
 
Structural only = 12  
Functional only = 12 
Structural and functional = 6 
Figure 1
